Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease
Xia Jiang, Ziwen Zhang, Jiawei Zuo, Chengyao Wu, Liang Zha, Yingying Xu, Sheng Wang, Jingbo Shi, Xinhua Liu, Jing Zhang, Wenjian Tang
Topics & Concepts
RivastigmineChemistryDonepezilCannabidiolPharmacologyButyrylcholinesteraseCarbamateNeuroprotectionTacrineAcetylcholinesteraseDocking (animal)IC50Drug discoveryAchéDementiaBiochemistryEnzymeDiseaseIn vitroMedicineInternal medicineNursingPsychiatryCannabisCannabis and Cannabinoid ResearchCholinesterase and Neurodegenerative DiseasesNatural Antidiabetic Agents Studies